levofloxacine
      J - Antiinfectives For Systemic Use -> J01 - Antibacterials For Systemic Use -> J01M - Quinolone Antibacterials -> J01MA - Fluoroquinolones -> J01MA12 - Levofloxacin
    
          
        Administration category:
         Free
      
    
          
        Medicine group:
        antibacterial
      
    
    
          
        Brand name:
                  Tavanic
              
      Safety margins
| Weight | ROA | Dosage | 
|---|---|---|
| ROA: po | Dosage: min. 250mg 1 dd to max. 500mg 2 dd | |
| ROA: iv | Dosage: min. 250mg 1 dd to max. 500mg 2 dd | 
Dosage for "I" sensitivity
| Weight | ROA | Load | Dosage | 
|---|---|---|---|
| ROA: po | Load: - | Dosage: 500mg 2 dd | |
| ROA: iv | Load: - | Dosage: 500mg 2 dd | 
Kidney function
| ROA | GFR | Dosage | Interval | Comments | 
|---|---|---|---|---|
| ROA: iv | ||||
| GFR: 30 - 50 | Dosage: 50% | Comments: 1e gift normale dosis | ||
| GFR: 10 - 30 | Dosage: 25% | Comments: 1e gift normale dosis | ||
| ROA: po | ||||
| GFR: 30 - 50 | Dosage: 50% | Comments: 1e gift normale dosis | ||
| GFR: 10 - 30 | Dosage: 25% | Comments: 1e gift normale dosis | ||
              
                Renal elimination: 
                93%
              
            
                    
                                
              
                Dosage: 
                dependent on kidney function
              
            
                    
        Renal function-replacement therapy
CAPD: Normale startdosis, vervolgens 25% van de normale keerdosis bij gelijkblijvend doseringsinterval.
Hemo dialysis: Normale startdosis, vervolgens 25% van de normale keerdosis bij gelijkblijvend doseringsinterval.
CAV / VVHD: Normale startdosis, vervolgens 25% van de normale keerdosis bij gelijkblijvend doseringsinterval.
Interactions
| Interaction with (ATC): | Interaction with: | Expected effect: | 
|---|---|---|
| Interaction with (ATC): | Interaction with: aluminium- en magnesiumzouten bevattende antacida | Expected effect: vermindering absorptie levofloxacine | 
| Interaction with (ATC): | Interaction with: ijzerzouten | Expected effect: vermindering absorptie levofloxacine | 
| Interaction with (ATC): R03DA04 - Theophylline | Interaction with: | Expected effect: verhoging plasmaconcentratie theofylline | 
Pregnancy
Due to the expiration of the alphanumeric classification for use in pregnancy and lactation, reference is made to the current, online information of the Teratology Information Service (TIS) of LAREB:
- http://www.lareb.nl//Teratologie/Naslagwerk-GZB/GZB---Zwangerschap#TOC_Middelen_bij6
- http://www.lareb.nl//Teratologie/Naslagwerk-GZB/GZB---Borstvoeding#TOC_Middelen_bij16
          
            For individual advice, consult an expert on site.          
        
      Metadata
            Swab vid: M-1520.4
            Updated: 04/07/2025 - 16:01
            Status: Published
          
